UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041353
Receipt number R000047212
Scientific Title Comparison of remimazolam and propofol on emergence in awake craniotomy: a randomized comparative study
Date of disclosure of the study information 2020/08/11
Last modified on 2023/12/13 14:30:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of remimazolam and propofol on emergence time in patients who undergo awake craniotomy: a randomized comparative study

Acronym

Efficacy of remimazolam and propofol in awake craniotomy

Scientific Title

Comparison of remimazolam and propofol on emergence in awake craniotomy: a randomized comparative study

Scientific Title:Acronym

Efficacy of remimazolam and propofol in awake craniotomy

Region

Japan


Condition

Condition

brain tumor

Classification by specialty

Anesthesiology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Awake craniotomy is applied for resection of brain tumor in temporal lobe and performed to improve the postoperative function. The aim of this study is the comparison of remimazolam, ultra-short acting benzodiazepin, and propofol, conventional sedative, concerning about time needed for emergence from anesthesia.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Time needed for emergence from general anesthesia

Key secondary outcomes

Time needed for extubation
Time course of sedation score
Time course of bispectral index
Serum concentration of remimazolam
Blood pressure, heart rate and SpO2 during general anesthesia
Incidence of awake craniotomy failure
Incidence of flumazenil administration
Doses of sedatives at re-anesthetic induction
Time needed for re-anesthetic induction


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Remimazolam is administered as a sedative in awake craniotomy

Interventions/Control_2

Propofol is administered as a sedative in awake craniotomy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who undergo awake craniotomy using asleep-awake-asleep procedure
Patients whose ASA-PS is 1 or 2, indicating their physical status are good

Key exclusion criteria

Patients diagnosed as severe cognitive dysfunction in preoperative period
Patients who have allergy for propofol, remimazolam and flumazenil
Patients who have severe hepatic dysfunction and/or renal dysfunction
Patients determined as inappropriate to include by researcher of this study

Target sample size

126


Research contact person

Name of lead principal investigator

1st name Shunsuke
Middle name
Last name Tachibana

Organization

Sapporo Medical University School of Medicine

Division name

Department of Anesthesiology

Zip code

0608543

Address

291, South 1, West 16, Chuo-ku, Sapporo

TEL

011-611-2111

Email

shunsuke.tachibana@gmail.com


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Chaki

Organization

Sapporo Medical University School of Medicine

Division name

Department of Anesthesiology

Zip code

0608543

Address

291, South 1, West 16, Chuo-ku, Sapporo

TEL

011-611-2111

Homepage URL


Email

chakitomohiro0728@yahoo.co.jp


Sponsor or person

Institute

Sapporo Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Sapporo Medical University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Sapporo Medical School of University Hospital

Address

291, South 1, West 16, Chuo-ku, Sapporo

Tel

011-611-2111

Email

chakitomohiro0728@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 08 Month 03 Day

Date of IRB

2020 Year 07 Month 09 Day

Anticipated trial start date

2020 Year 08 Month 11 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 08 Month 07 Day

Last modified on

2023 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047212


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name